Russian Association of Endocrinologists reports commencement of Trajenta clinical use

Bibliographic Details
Main Author: Editorial team Diabetes Mellitus
Format: Article
Language:English
Published: Endocrinology Research Centre 2012-12-01
Series:Сахарный диабет
Subjects:
Online Access:https://www.dia-endojournals.ru/jour/article/view/5553
_version_ 1797255251676364800
author Editorial team Diabetes Mellitus
author_facet Editorial team Diabetes Mellitus
author_sort Editorial team Diabetes Mellitus
collection DOAJ
first_indexed 2024-03-08T15:21:56Z
format Article
id doaj.art-fbeca3c5dbc146cc9c935f247bbc1bb4
institution Directory Open Access Journal
issn 2072-0351
2072-0378
language English
last_indexed 2024-04-24T22:02:53Z
publishDate 2012-12-01
publisher Endocrinology Research Centre
record_format Article
series Сахарный диабет
spelling doaj.art-fbeca3c5dbc146cc9c935f247bbc1bb42024-03-20T11:47:58ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782012-12-0115413413510.14341/2072-0351-55535511Russian Association of Endocrinologists reports commencement of Trajenta clinical useEditorial team Diabetes Mellitushttps://www.dia-endojournals.ru/jour/article/view/5553russian association of endocrinologistsdiabetes mellitusdpp-4 inhibitorlinagliptintrajenta
spellingShingle Editorial team Diabetes Mellitus
Russian Association of Endocrinologists reports commencement of Trajenta clinical use
Сахарный диабет
russian association of endocrinologists
diabetes mellitus
dpp-4 inhibitor
linagliptin
trajenta
title Russian Association of Endocrinologists reports commencement of Trajenta clinical use
title_full Russian Association of Endocrinologists reports commencement of Trajenta clinical use
title_fullStr Russian Association of Endocrinologists reports commencement of Trajenta clinical use
title_full_unstemmed Russian Association of Endocrinologists reports commencement of Trajenta clinical use
title_short Russian Association of Endocrinologists reports commencement of Trajenta clinical use
title_sort russian association of endocrinologists reports commencement of trajenta clinical use
topic russian association of endocrinologists
diabetes mellitus
dpp-4 inhibitor
linagliptin
trajenta
url https://www.dia-endojournals.ru/jour/article/view/5553
work_keys_str_mv AT editorialteamdiabetesmellitus russianassociationofendocrinologistsreportscommencementoftrajentaclinicaluse